Cytomegalovirus Antibodies?
Lab Reagents
Cytomegalovirus Antibody Laboratories manufactures the cytomegalovirus antibodies? reagents distributed by Genprice. The Cytomegalovirus Antibodies? reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact cytomegalovirus Antibody. Other Cytomegalovirus products are available in stock. Specificity: Cytomegalovirus Category: Antibodies?
Anti-Human Cytomegalovirus antibody |
|||
| STJ16100451 | St John's Laboratory | 1 mL | EUR 1092 |
Anti-Cytomegalovirus p65 antibody |
|||
| STJ16101049 | St John's Laboratory | 100 µg | EUR 424.8 |
Anti-Cytomegalovirus p65 antibody |
|||
| STJ16101050 | St John's Laboratory | 100 µg | EUR 424.8 |
Anti-Cytomegalovirus p65 antibody |
|||
| STJ16101051 | St John's Laboratory | 100 µg | EUR 424.8 |
Cytomegalovirus Antibody / CMV / PP65 |
|||
| V2332-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
|||
Cytomegalovirus Antibody / CMV / PP65 |
|||
| V2332-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
|||
Cytomegalovirus Antibody / CMV / PP65 |
|||
| V2332SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
|||
Cytomegalovirus Antibody / CMV / PP65 |
|||
| V2333-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
|||
Cytomegalovirus Antibody / CMV / PP65 |
|||
| V2333-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
|||
Cytomegalovirus Antibody / CMV / PP65 |
|||
| V2333SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
|||
Human cytomegalovirus 65KDA phosphoprotein (UL83) |
|||
| 1-CSB-EP361930HWV | Cusabio |
|
|
|
Description: Recombinant Human cytomegalovirus 65KDA phosphoprotein(UL83),partial expressed in E.coli |
|||
Mouse Anti Cytomegalovirus Monoclonal Antibody |
|||
| DMABT-51183MC | Creative Diagnostics | 0.1 mg | EUR 920.4 |
Cytomegalovirus Envelope Glycoprotein H Antibody |
|||
| 20-abx109273 | Abbexa |
|
|
Cytomegalovirus Envelope Glycoprotein L Antibody |
|||
| 20-abx109402 | Abbexa |
|
|
Cytomegalovirus (CMV) Chimeric 1 Protein |
|||
| abx061513-1mg | Abbexa | 1 mg | EUR 1796.4 |
Cytomegalovirus gH (CMV gH) Antibody |
|||
| abx415688-01mg | Abbexa | 0.1 mg | EUR 777.6 |
Goat polyclonal antibody for Cytomegalovirus |
|||
| 801 | Virostat | 1 ml | EUR 327.53 |
|
Description: This is goat polyclonal antibody against Cytomegalovirus AD 169 for WB, ELISA. |
|||